`ilacgelistirme` ile İlgili Madde Sonuçları

Valo Health is a technology-driven biopharmaceutical company dedicated to transforming the drug discovery and development process through AI-powered integration of large-scale human data. The company’s mission is to unify every stage of drug development — from target identification to clinical design — within a single, intelligent computational architecture. This approach aims to reduce the cost, duration, and failure rate of drug development while accelerating the delivery of new treatments to

Insitro is a biotechnology company that integrates machine learning and high-throughput biology to redefine the process of drug discovery and development through data-driven science. Founded in 2018 by computer scientist Daphne Koller, the company is headquartered in South San Francisco, California. Insitro’s mission is to accelerate the development of more effective and accessible medicines by decoding the complexity of human diseases through the measurement and modeling of biological data. Mis

Deep Genomics is a biotechnology company specializing in artificial intelligence–driven genetic therapy development. Headquartered in Toronto, Ontario, Canada, with an additional office in Boston, Massachusetts, the company operates on the principle that the future of medical innovation lies in artificial intelligence, given the inherent complexity of biological systems. Deep Genomics develops AI-based biological models to identify and treat genetic disorders. Scientific Approach and Research Fo

Healx is a technology-driven biotechnology company that combines artificial intelligence and drug development expertise to accelerate the discovery of new treatments for rare diseases. Founded in 2014 by Dr. Tim Guilliams and Dr. David Brown in Cambridge, United Kingdom, Healx aims to address the global challenge that only about 5% of nearly 10,000 known rare diseases currently have an approved therapy. The company adopts a patient-inspired approach, focusing on overcoming barriers faced by rare

XtalPi is a technology company that integrates quantum physics–based computational methods, artificial intelligence, and robotic automation to accelerate and scale drug research and development. Operating across China and the United States, the company coordinates computational and experimental resources to meet the needs of clients and collaborators. Its iterative feedback loop between in silico (dry lab) modeling and wet-lab experimentation enables continuous optimization through cloud superco

Atomwise is a biotechnology company specializing in AI-powered drug discovery, recognized as the first organization to apply deep learning to structure-based drug design. The company’s approach leverages artificial intelligence to predict how small-molecule drug candidates interact with target proteins, accelerating the development of novel therapeutics—especially against previously “undruggable” targets. Technology and Research Approach The company’s core technology, AtomNet®, is a deep convolu

Generate:Biomedicines is a next-generation biotechnology company integrating machine learning, bioengineering, and medicine to revolutionize therapeutic protein design. Through its proprietary Generative Biology™ approach, the company enables the programming of protein-based therapeutics, fundamentally transforming the way drugs are discovered and developed. Headquartered in Somerville, Massachusetts, Generate:Biomedicines is a venture of Flagship Pioneering, founded on the principle that biolog

Erisyon, tek molekül düzeyinde protein dizilemesi gerçekleştiren dünyanın ilk protein dizileme teknolojisini ticarileştiren biyoteknoloji şirketidir. Şirket, proteomik alanında yüksek hassasiyet ve ölçeklenebilirlik sağlayarak yaşam bilimlerinde yeni araştırma ve tanı uygulamalarının önünü açmaktadır. Erisyon’un geliştirdiği Fluorosequencing yöntemi, proteinleri tek tek analiz etme kapasitesi sayesinde hastalıkların erken tespiti, izlenmesi ve tedavisinde önemli bir yenilik olarak kabul edilmekt

XtalPi, kuantum fiziğine dayalı hesaplamalı yöntemler, yapay zekâ ve robotik otomasyonu birleştirerek ilaç araştırma-geliştirme süreçlerini hız ve ölçek açısından dönüştürmeyi amaçlayan bir teknoloji şirketidir. Şirket, Çin ve Amerika Birleşik Devletleri’ndeki operasyonları üzerinden müşteriler ve işbirlikçilerin gereksinimlerine uygun kaynakları dağıtır. Kuru laboratuvar (in silico) ile ıslak laboratuvar arasında kurulan yinelemeli geri besleme döngüsü, bulut süper bilgi-işlem üzerinde çalışan

BioAge Labs is a clinical-stage biotechnology company developing novel therapeutic targets and drug candidates for metabolic diseases by decoding the biology of aging. Headquartered in Emeryville, California, the company applies a data-driven approach to understanding the biological foundations of human aging. Research Platform BioAge’s proprietary discovery platform integrates over 65 million molecular measurements derived from more than 45 years of human aging data. By analyzing mechanisms lin